Ausgabe 1/2023
Spotlight: Heart Failure
Inhalt (15 Artikel)
Expert proposal to characterize cardiac diseases with normal or preserved left ventricular ejection fraction and symptoms of heart failure by comprehensive echocardiography
A. Hagendorff, A. Helfen, R. Brandt, E. Altiok, O. Breithardt, D. Haghi, J. Knierim, D. Lavall, N. Merke, C. Sinning, S. Stöbe, C. Tschöpe, F. Knebel, S. Ewen
Heart failure-related quality-of-life impairment after myocardial infarction
Peter Wohlfahrt, Dominik Jenča, Josef Stehlik, Vojtěch Melenovský, Jolana Mrázková, Vladimír Staněk, Jiří Kettner, Marek Šramko, Michael Želízko, Věra Adámková, Jan Piťha, Josef Kautzner
Symptom burden, psychosocial distress and palliative care needs in heart failure – A cross-sectional explorative pilot study
F. Strangl, E. Ischanow, A. Ullrich, K. Oechsle, N. Fluschnik, C. Magnussen, D. Knappe, H. Grahn, S. Blankenberg, C. Bokemeyer, P. Kirchhof, M. Rybczynski
Relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure
Guido Grassi, Gino Seravalle, Jennifer Vanoli, Rita Facchetti, Domenico Spaziani, Giuseppe Mancia
Reliability of estimating left ventricular ejection fraction in clinical routine: a validation study of the SWEDEHEART registry
Joel Lenell, Bertil Lindahl, Per Karlsson, Gorav Batra, David Erlinge, Tomas Jernberg, Jonas Spaak, Tomasz Baron
Lack of correlation between different congestion markers in acute decompensated heart failure
Svenja Haag, Alexander Jobs, Thomas Stiermaier, Carlo-Federico Fichera, Christina Paitazoglou, Ingo Eitel, Steffen Desch, Holger Thiele
Body fluid regulation via chronic inhibition of sodium–glucose cotransporter-2 in patients with heart failure: a post hoc analysis of the CANDLE trial
Shinya Fujiki, Atsushi Tanaka, Takumi Imai, Michio Shimabukuro, Hiroki Uehara, Ikuko Nakamura, Kazuo Matsunaga, Makoto Suzuki, Takeshi Kashimura, Tohru Minamino, Takayuki Inomata, Koichi Node
Nighttime hemodynamic phenotype. A novel risk factor for cardiovascular disease, especially heart failure: the practitioner-based nationwide JAMP study
Kazuomi Kario, Satoshi Hoshide, Hiroyuki Mizuno, Tomoyuki Kabutoya, Masafumi Nishizawa, Tetsuro Yoshida, Hideyasu Abe, Tomohiro Katsuya, Yukie Okawara, Hiroshi Kanegae
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
Sam Straw, Charlotte A. Cole, Melanie McGinlay, Michael Drozd, Thomas A. Slater, Judith E. Lowry, Maria F. Paton, Eylem Levelt, Richard M. Cubbon, Mark T. Kearney, Klaus K. Witte, John Gierula
Comorbidities complicating heart failure: changes over the last 15 years
Elles M. Screever, Martje H. L. van der Wal, Dirk J. van Veldhuisen, Tiny Jaarsma, Astrid Koops, Kuna S. van Dijk, Janke Warink-Riemersma, Jenifer E. Coster, B. Daan Westenbrink, Peter van der Meer, Rudolf A. de Boer, Wouter C. Meijers
The SGLT2 inhibitor empagliflozin reduces tissue sodium content in patients with chronic heart failure: results from a placebo-controlled randomised trial
Julie Kolwelter, Dennis Kannenkeril, Peter Linz, Susanne Jung, Armin M. Nagel, Agnes Bosch, Christian Ott, Peter Bramlage, Lisa Nöh, Mario Schiffer, Michael Uder, Stephan Achenbach, Roland E. Schmieder
Clinical trajectories and outcomes of patients with heart failure with preserved ejection fraction with normal or indeterminate diastolic function
Bolrathanak Oeun, Shungo Hikoso, Daisaku Nakatani, Hiroya Mizuno, Tetsuhisa Kitamura, Katsuki Okada, Tomoharu Dohi, Yohei Sotomi, Hirota Kida, Akihiro Sunaga, Taiki Sato, Yuki Matsuoka, Hiroyuki Kurakami, Tomomi Yamada, Shunsuke Tamaki, Masahiro Seo, Masamichi Yano, Takaharu Hayashi, Akito Nakagawa, Yusuke Nakagawa, Takahisa Yamada, Yoshio Yasumura, Yasushi Sakata, Masahiro Seo, Tetsuya Watanabe, Takahisa Yamada, Takaharu Hayashi, Yoshiharu Higuchi, Masaharu Masuda, Mitsutoshi Asai, Toshiaki Mano, Hisakazu Fuji, Shunsuke Tamaki, Daisaku Masuda, Ryu Shutta, Shizuya Yamashita, Masami Sairyo, Yusuke Nakagawa, Haruhiko Abe, Yasunori Ueda, Yasushi Matsumura, Kunihiko Nagai, Masamichi Yano, Masami Nishino, Jun Tanouchi, Yoh Arita, Nobuyuki Ogasawara, Takamaru Ishizu, Minoru Ichikawa, Yuzuru Takano, Eisai Rin, Yukinori Shinoda, Koichi Tachibana, Shiro Hoshida, Masahiro Izumi, Hiroyoshi Yamamoto, Hiroyasu Kato, Kazuhiro Nakatani, Yuji Yasuga, Mayu Nishio, Keiji Hirooka, Takahiro Yoshimura, Kazunori Kashiwase, Shinji Hasegawa, Akihiro Tani, Yasushi Okumoto, Yasunaka Makino, Toshinari Onishi, Katsuomi Iwakura, Yoshiyuki Kijima, Takashi Kitao, Masashi Fujita, Koichiro Harada, Masahiro Kumada, Osamu Nakagawa, Akito Nakagawa, Yoshio Yasumura, Yuki Matsuoka, Taiki Sato, Akihiro Sunaga, Bolrathanak Oeun, Hirota Kida, Yohei Sotomi, Tomoharu Dohi, Yasuhiro Akazawa, Kei Nakamoto, Katsuki Okada, Fusako Sera, Hidetaka Kioka, Tomohito Ohtani, Toshihiro Takeda, Daisaku Nakatani, Hiroya Mizuno, Shungo Hikoso, Yasushi Sakata
Defining the gap in heart failure treatment in patients with cardiac implantable electronic devices
Samaneh Salimian, Nima Moghaddam, Marc W. Deyell, Sean A. Virani, Matthew T. Bennett, Andrew D. Krahn, Jason G. Andrade, Nathaniel M. Hawkins
Real-world comparative effectiveness of ARNI versus ACEi/ARB in HF with reduced or mildly reduced ejection fraction
Michael Fu, Aldina Pivodic, Oskar Käck, Madlaina Costa-Scharplatz, Ulf Dahlström, Lars H. Lund
Correction: Relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure
Guido Grassi, Gino Seravalle, Jennifer Vanoli, Rita Facchetti, Domenico Spaziani, Giuseppe Mancia